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Abstract The increasing incidence of infectious
diseases caused by fungi in immunocompromised
patients has encouraged researchers to develop rapid
and accurate diagnosis methods. Identification of the
causative fungal species is critical in deciding the
appropriate treatment, but it is not easy to get
satisfactory results due to the difficulty of fungal
cultivation and morphological identification from
clinical samples. In this study, we established a
microarray system that can identify 42 species from
24 genera of clinically important fungal pathogens by
using a chemical color reaction in the detection
process. The array uses the internal transcribed spacer
region of the rRNA gene for identification of fungal
DNA at the species level. The specificity of this array
was tested against a total of 355 target and nontarget
fungal species. The fungal detection was succeeded
directly from 103 CFU/ml for whole blood samples,
and 50 fg DNA per 1 ml of serum samples indicating
that the array system we established is sensitive to
identify infecting fungi from clinical sample. Further-
more, we conducted isothermal amplification in place
of PCR amplification and labeling. The successful
identification with PCR-amplified as well as isother-
mally amplified target genes demonstrated that our
microarray system is an efficient and robust method
for identifying a variety of fungal species in a sample.
Keywords Diagnosis  Microarray  Fungal
infection  Isothermal amplification
Introduction
Systemic fungal infections with high morbidity and
mortality rates in immunocompromised patients are
growing. Besides the increasing incidence, recent
epidemiology of fungal infection shows the expanding
variety of fungal pathogens [1].
Identification of the causative pathogen is a funda-
mental step for appropriate treatment of infectious
diseases, and early initiation of antifungal therapy is
crucial for reducing the mortality rate in infected
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patients. Despite efforts by many researchers, how-
ever, early and rapid diagnosis of systemic fungal
infection remains limited. Conventional diagnostic
procedures, such as cultivation of fungi from clinical
samples, are time-consuming and suffer from low
sensitivity. Furthermore, sufficient technique and
experience are required at the identification step. In
recent years, other methods, such as PCR and
serological tests, have been established for rapid and
sensitive detection of fungi from clinical samples [2,
3]. However, these methods are difficult to use to
identify a variety of fungal species at a time. Although
multiplex PCR can be used to identify several species
in one test, its applicability is limited by the primer sets
used because specific primer sets are needed for each
species.
A variety of DNA array systems have been
developed to identify several bacteria and/or fungi
simultaneously with high sensitivity and specificity
[4–8]. Fluorescent labels are widely used to detect the
signal in DNA microarrays due to their high sensitiv-
ity. However, the low stability of most fluorescent
dyes and the necessity of expensive scanning equip-
ment call for the development of alternative labeling
systems that are inexpensive and robust.
To facilitate the diagnosis of fungal infectious
disease, we established a rapid and specific DNA
microarray system for identifying a variety of caus-
ative fungal species simultaneously. We applied the
chemical color reaction of biotin-peroxidase and its
substrate as the signal detection for the microarray
system, enabling examination of the spot pattern with
the naked eyes, without the need for expensive
scanning equipment. To evaluate the specificity and
sensitivity of this visible DNA microarray system, we
tested it on several kinds of samples, such as reference
fungal strains, blood samples containing a certain
number of fungal cells, serum samples with serial
dilutions of fungal DNA, and blood culture samples
from patients.
Conventional PCR methods have been used for
labeling and amplifying DNA from pathogen in
microarray identification systems, but this method
could not be used for bedside analysis and therefore
difficult to be widely adopted. Recently, several
isothermal amplification methods that do not require
expensive thermal cyclers, such as loop-mediated
isothermal amplification (LAMP), helicase-dependent
amplification (HAD), and isothermal and chimeric
primer-initiated amplification of nucleic acids
(ICAN), have been developed to replace PCR ampli-
fication [9–12]. However, the maximum amplifiable
length of the products in these isothermal methods is
too small (100–500 bp) for our purposes, making
primer design difficult. Hence, in this study, we
applied the recombinase polymerase amplification
cycle (RPA) for labeling and amplification of DNA
products from the pathogen for microarray detection
[13]. The RPA technology is based on a combination
of polymerases and DNA recombinases. These
enzyme mixtures are active at low temperature
(optimum around 37 C) and recognize template
target sites by oligonucleotide primers, followed by
strand-displacing DNA synthesis. Thus, exponential
DNA amplification of the target region is proceeded
under the isothermal condition.
Materials and Methods
Microorganisms and Growth Conditions
A total of 355 strains were obtained from the Medical
Mycology Research Center IFM Collection (Chiba
university, Japan) (Table S1). All fungal strains were
cultivated on PDA medium at appropriate tempera-
tures. Small amount of fungal cells were picked by
toothpick and suspended in distilled water to become
little bit cloudy solution and used as template for PCR
amplification.
Design of Capture Probes
The fungal oligonucleotide probes were designed
based on the whole internal transcribed spacer (ITS)
sequences regions available in the GenBank database
and from our own sequencing data. The alignment was
prepared by BioEdit using several objective and
nonobjective fungal ITS sequences as listed in Table
S2. After sequence alignment, species- or genus-
specific oligonucleotide sequences were selected to be
unique to each species/genus. To evaluate the speci-
ficities against other organisms, we performed addi-
tional BLASTN searches of the GenBank database.
The designed probes were consisted of 14–21 species/
genus-specific oligonucleotides and a poly-T anchor at
the end of the oligonucleotides [14]. Detailed
sequences of the capture probes are given in Table 1.
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Table 1 Oligonucleotide sequence of probes
Organism Probe name Probe sequence (50-30) Length (bp)






Absidia corymbifera Ab3-19t CCGGATGGAGACTCTAGAGTTTTTTTTTT 29
Ab2-18Rt ATTTAAGGCCATGACAGCTTTTTTTTTT 28
Ab2-t18R TTTTTTTTTTATTTAAGGCCATGACAGC 28




Aspergillus flavus 60B 1 TTTTTTTTTTTGATCTAGTGAAGTCTGAG 29
60B 1R TTTTTTTTTTCTCAGACTTCACTAGATCA 29
60B 17R TCAGACTTCACTAGATCTTTTTTTTTT 27
60C 1R TTTTTTTTTTTAACTGATTGCGATACAAT 29
60C 2R TTTTTTTTTTACTGATTGCGATACAAT 27
60C-19R TAACTGATTGCGATACAATTTTTTTTTTT 29
Aspergillus fumigatus 33B-1R TTTTTTTTTTTAACTGATTACGATAATCAA 30
33B-2R TTTTTTTTTTTAACTGATTACGATAATCA 29
33B-4R TAACTGATTACGATAATCAATTTTTTTTTT 30
33C 1R TTTTTTTTTTTAACTGATTACGATAATCAAC 31
33C 2R TTTTTTTTTTACTGATTACGATAATCAAC 29





Aspergillus nidulans 64B 8 TTTTTTTTTTAGTTCAGTGGTCCCCGGC 28
64B 9 TTTTTTTTTTAGTTCAGTGGTCCCCG 26
65A 15 GGCGTCTCCAACCTTTTTTTTTTTT 25
65A 17 CGGCGTCTCCAACCTTATTTTTTTTTT 27
65A 19 CCGGCGTCTCCAACCTTATTTTTTTTTTT 29
Aspergillus niger 62A 4 TTTTTTTTTTATAGACACGGATG 23
63A 15 TTTTTTTTTTCCAACCATTCTTTCCA 26
63A 17 TTTTTTTTTTTCCAACCATTCTTTCCA 27
63A 19 TTTTTTTTTTTTCCAACCATTCTTTCCAG 29
Aspergillus terreus 35A 17R GCAAAGAATCACACTCATTTTTTTTTT 27
35A 19 TGAGTGTGATTCTTTGCAATTTTTTTTTT 29
35A 19R TTGCAAAGAATCACACTCATTTTTTTTTT 29
36A 1 TTTTTTTTTTGGCTTCGTCTTCCGCTCCG 29
36A 2 TTTTTTTTTTGCTTCGTCTTCCGCTCC 27
36A 19 GGCTTCGTCTTCCGCTCCGTTTTTTTTTT 29
36B 15 CGACGCATTTATTTGTTTTTTTTTT 25
Mycopathologia (2014) 178:11–26 13
123
Table 1 continued
Organism Probe name Probe sequence (50-30) Length (bp)
36B 17 GCCGACGCATTTATTTGTTTTTTTTTT 27
36B 19 CGCCGACGCATTTATTTGCTTTTTTTTTT 29
Blastomyces dermatitidis 41A 17R GTTCCTCCGGTCTAGGATTTTTTTTTT 27
41A 19R GGTTCCTCCGGTCTAGGAGTTTTTTTTTT 29
42A 15 CCGGCCCCATCTCAATTTTTTTTTT 25
42A 17 TCCGGCCCCATCTCAAATTTTTTTTTT 27
Candida albicans 14A 15 CGGAGATGCTTGACTTTTTTTTTTT 25
14A 17 CGGAGATGCTTGACAATTTTTTTTTTT 27
1A 17R TTTTTTTTTTAAGTTTAGACCTCTGGC 27
1A 19 CCGCCAGAGGTCTAAACTTTTTTTTTTTT 29
1B 15R TTTTTTTTTTATCTGGTGTGACAAG 25
1B 17R TTTTTTTTTTTAATCTGGTGTGACAAG 27
1B 19 ACTTGTCACACCAGATTATTTTTTTTTTT 29
2A 15 CGTCCACCACGTATATTTTTTTTTT 25
2A 17 AACGTCCACCACGTATATTTTTTTTTT 27
2A 19 GTAACGTCCACCACGTATATTTTTTTTTT 29
2B 15 TTTTTTTTTTATTGCTTGCGGCGGT 25
2B 17 TTTTTTTTTTACATTGCTTGCGGCGGT 27
Candida dubliniensis 13A-2R TTTTTTTTTTAACAAAACACATGTGGT 27
13A-3R TTTTTTTTTTAACAAAACACATGTGG 26
13B 15 TTTTTTTTTTTATAAACTTGTCACG 25
13B 17 TTTTTTTTTTTATAAACTTGTCACGAG 27




Candida glabrata 7A 15R TTTTTTTTTTTGTCTCTCTCCGAGC 25
7A 17R TTTTTTTTTTATGTCTCTCTCCGAGCT 27
7A 19R TTTTTTTTTTGATGTCTCTCTCCGAGCTC 29
7B 17 CTCCTGCCTGCGCTTAATTTTTTTTTT 27
7B 19 TTCTCCTGCCTGCGCTTAATTTTTTTTTT 29
7B 19R TTAAGCGCAGGCAGGAGAATTTTTTTTTT 29
8A 17 TTTTTTTTTTAACTTGAAATTGTAGGC 27
8A 19 TTTTTTTTTTAACTTGAAATTGTAGGCCA 29
8B 15 TTTTTTTTTTTGCTGCTCGTTTGCG 25
8B 17 TTTTTTTTTTTTGCTGCTCGTTTGCGC 27
8B 19 TTTTTTTTTTTCTGCTGCTCGTTTGCGCG 29
Candida guilliermondii 55A 17R TTTTTTTTTTAAAATTTGACTAACTGT 27
55A 19 TTTACAGTTAGTCAAATTTTTTTTTTTTT 29
55A 19R TTTTTTTTTTCAAAATTTGACTAACTGTA 29
55B 15 GTCGACCTCTCAATGTTTTTTTTTT 25
55B 17 TGTCGACCTCTCAATGTTTTTTTTTTT 27
55B 19 CTGTCGACCTCTCAATGTATTTTTTTTTT 29
Candida kefyr Ck1-t16R TTTTTTTTTTGTCAGACGATTCCCCC 26
Ck2-20Rt TAGCAGAGAATCAAGAACTGTTTTTTTTTT 30
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Table 1 continued






Candida krusei 9B 17R GCTATATTCCACATTTTTTTTTTTTTT 27




10A 15 GCGGACGACGTGTAATTTTTTTTTT 25
10A 17 GCGGACGACGTGTAAAGTTTTTTTTTT 27
10A 19 GAGCGGACGACGTGTAAAGTTTTTTTTTT 29
10B 15 TTTTTTTTTTGAGCGAAGCTGGCCG 25
10B 17 TTTTTTTTTTAGCGAAGCTGGCCGAGC 27
10B 19 TTTTTTTTTTGAGCGAAGCTGGCCGAGCG 29
Candida lusitaniae 11C 14R TGTTCGCAAAAACATTTTTTTTTT 24
11C 15R TGTTCGCAAAAACAATTTTTTTTTT 25
11C 16R TGTTCGCAAAAACAATTTTTTTTTTT 26
11B 19 TTCGAATTTCTTAATATCATTTTTTTTTT 29
11B 19R TTGATATTAAGAAATTCGATTTTTTTTTT 29
12A 17R TTTCGGAGCAACGCCTATTTTTTTTTT 27
12A 19 TTAGGCGTTGCTCCGAAATTTTTTTTTT 29
12A 19R TTTCGGAGCAACGCCTAACTTTTTTTTTT 29
12B 17 CGTTTACAGCACGACATTTTTTTTTTT 27
12B 19 CACGTTTACAGCACGACATTTTTTTTTTT 29
Candida rugosa 17B 15R GATCGGTACTTGAAGTTTTTTTTTT 25
18B 15R TTTTTTTTTTAGACGGTCGCGTTTC 25
Candida parapsilosis 5A 17 CTGCCAGAGATTAAACTTTTTTTTTTT 27
5A 18 CTGCCAGAGATTAAACTCTTTTTTTTTT 28
5A 18R GAGTTTAATCTCTGGCAGTTTTTTTTTT 28
6A 17 TTTTTTTTTTCCAAAACTTCTTCCATT 27
6A 19 TTTTTTTTTTCTCCAAAACTTCTTCCATT 29
6A 19R TTTTTTTTTTAATGGAAGAAGTTTTGGAG 29
6B 17 TTTTTTTTTTACTCCAAAACTTCTTCC 27
6B 18 TTTTTTTTTTACTCCAAAACTTCTTCCA 28
6B 18R TTTTTTTTTTTGGAAGAAGTTTTGGAGT 28
Candida tropicalis 3A 16R TTTTTTTTTTGGATTGCTCCCGCCAC 26
3A 17R TTTTTTTTTTGGATTGCTCCCGCCACC 27
3B 15R TTTTTTTTTTATCAAGTTTGACTGT 25
3B 17R TTTTTTTTTTAAATCAAGTTTGACTGT 27
3B 19R TTTTTTTTTTAAATCAAGTTTGACTGTAA 29
4A 15 TTTTTTTTTTATACGCTAGGTTTGT 25
4A 17 TTTTTTTTTTATACGCTAGGTTTGTTT 27
4A 19 TTTTTTTTTTCAATACGCTAGGTTTGTTT 29
Mycopathologia (2014) 178:11–26 15
123
Table 1 continued
Organism Probe name Probe sequence (50-30) Length (bp)
4B 17 GCTAGTGGCCACCACTTTTTTTTTTTT 27
4B 19 GCTAGTGGCCACCACAATTTTTTTTTTTT 29
Candida zeylanoides 15A 19 GTTTTATACTAAAACTTCATTTTTTTTTT 29
15A 1 GGTTTTATACTAAAACTTCATTTTTTTTTT 30
15B 1 TTTTTTTTTTATTGAATTGTTAATTAATTA 30
15B 1R TTTTTTTTTTTAATTAATTAACAATTCAAT 30
16A 19 TTTTTTTTTTGACCAGTATAGTATTTGT 28
16A 17 TTTTTTTTTTACCAGTATAGTATTTG 26
Coccidioides posadasii 37C 15R GGAGGTGCGCAGCCGTTTTTTTTTT 25
37C 17R GGGAGGTGCGCAGCCGGTTTTTTTTTT 27
37C 19R GGGGAGGTGCGCAGCCGGATTTTTTTTTT 29
37E 15R TTTTTGCTATGATGCTTTTTTTTTT 25
37E 17R GATTTTTGCTATGATGCTTTTTTTTTT 27




38E 15 TTTTTTTTTTACCCGATCGGGGCCG 25
38E 17 TTTTTTTTTTGACCCGATCGGGGCCGA 27




22A 17 TTTTTTTTTTGTTTATGTGCTTCGGCA 27
23A 17 TTTTTTTTTTGAAGGTGATTACCTGTC 27
23A 19 TTTTTTTTTTGGAAGGTGATTACCTGTCA 29
23B 1 TTTTTTTTTTTTTCGCTGGGCCTATGG 27
23B 2 TTTTTTTTTTGTTTCGCTGGGCCTATGGG 29
Cryptococcus gattii 20-2R TTTTTTTTTTTGGACCGAAGCCCAGTATT 29
20-5R TTTTTTTTTTGACCGAAGCCCAGTATT 27
20-6R TTTTTTTTTTGGACCGAAGCCCAGTAT 27
Cunninghamella bertholletiae 70A-1R CCCAAAGATCCCTTGATCTATTTTTTTTTT 30
70A-2R CCCAAAGATCCCTTGATCTTTTTTTTTTT 29
71A 19 TAGTCGGCTTTAATAGATTTTTTTTTTTT 29
71A 17 TAGTCGGCTTTAATAGATTTTTTTTTT 27




Epidermophyton floccosum 76B 19R CTCAGACTGAACCACCTATTTTTTTTTTT 29
76B 17R TCAGACTGAACCACCTATTTTTTTTTT 27
76B 15R CAGACTGAACCACCTTTTTTTTTTT 25
77A 19 TTTTTTTTTTAGTTTCCGTCGGGAGGACG 29
77A 17 TTTTTTTTTTGTTTCCGTCGGGAGGAC 27
Fusarium sp. 7-16t GGCCACGCCGTTAAACTTTTTTTTTT 26
7-18t CTTCTGAATGTTGACCTCTTTTTTTTTT 28
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Table 1 continued
















Histoplasma capsulatum 39B-22 TTTTTTTTTTCGTTCACCGACGGTTCTT 28
39B-24 TTTTTTTTTTGTTCACCGACGGTTCT 26
39B-25 TTTTTTTTTTGTTCACCGACGGTTC 25
39C 15R AGGTCCGGTAGACAATTTTTTTTTT 25
39C 17R CAGGTCCGGTAGACAAGTTTTTTTTTT 27
39C 19R ACAGGTCCGGTAGACAAGGTTTTTTTTTT 29
Malassezia furfur 48A 15R TTTTTTTTTTCCAAACGGTGCACAC 25
48A 17R TTTTTTTTTTTCCAAACGGTGCACACG 27
48A 19R GATTTCCACGTTCATACAATTTTTTTTTT 29
48B 15R TTTCCACGTTCATACTTTTTTTTTT 25
48B 17R ATTTCCACGTTCATACATTTTTTTTTT 27
48B 19R GATTTCCACGTTCATACAATTTTTTTTTT 29
49A 7 TGCGATTGCACTGCTTTGTTTTTTTTTT 28
49A 8 GCGATTGCACTGCTTTGTTTTTTTTTT 27
49A 9 CGATTGCACTGCTTTGTTTTTTTTTT 26
49B 15 TTTTTTTTTTGCATTAGCGCCTTTG 25
49B 17 TTTTTTTTTTTGCATTAGCGCCTTTGG 27
49B 19 TTTTTTTTTTATGCATTAGCGCCTTTGGG 29
Microsporum canis 73A 6 TTTTTTTTTTGTAACCACCCACCGCTTA 28
73A 7 GTAACCACCCACCGCTTAGTTTTTTTTTT 29
73A 9 GTAACCACCCACCGCTTATTTTTTTTTT 28
73B 19 CGCACCATGTATTATTCAGTTTTTTTTTT 29
73B 17 GCACCATGTATTATTCATTTTTTTTTT 27
73B 1 TTTTTTTTTTCGCACCATGTATTATTCAG 29
Microsporum gypseum 74A 2R GATTTTACTTGCTAACGTTTTTTTTTT 27
74B 1 CGGAACAGTATTCATGGATTTTTTTTTTT 29
74B 2 GGAACAGTATTCATGGATTTTTTTTTT 27
74B 4 TTTTTTTTTTCGGAACAGTATTCATGGAT 29
Mucor sp. M1-t15R TTTTTTTTTTTAATACAGTTCACAG 25
M1-16Rt AATAATACAGTTCACATTTTTTTTTT 26
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Table 1 continued





Paracoccidioides brasiliensis 45A 15R CCCCGTCCCCCCACGTTTTTTTTTT 25
45A 17R GCCCCGTCCCCCCACGGTTTTTTTTTT 27
45A 18R GGCCCCGTCCCCCCACGGTTTTTTTTTT 28
45B 15R TTTTTTTTTTTCAAAGCTCCGAACC 25
45B 17R TTTTTTTTTTGTCAAAGCTCCGAACCA 27
45B 19R TTTTTTTTTTCGTCAAAGCTCCGAACCAG 29
46A 15 CCCCACTCATCGACCTTTTTTTTTT 25
46A 17 GCCCCACTCATCGACCCTTTTTTTTTT 27
46A 19 GGCCCCACTCATCGACCCCTTTTTTTTTT 29
Penicillium marneffei 43B 15R TTTTTTTTTTTCAGACAGTCCATCT 25
43B 17R TTTTTTTTTTCTCAGACAGTCCATCTT 27
43B 19R TTTTTTTTTTACTCAGACAGTCCATCTTC 29
44A 17 TTTTTTTTTTCCACCATATTTACCACG 27
44A 19 TTTTTTTTTTACCACCATATTTACCACGG 29
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Table 1 continued



















Scedosporium prolificans Scp2-t15R TTTTTTTTTTGTATTGTATTCAGAA 25
ScpP-19Rt GGCTTGTAAAAACCTAGGCTTTTTTTTTT 29
ScP-t19R TTTTTTTTTTGGCTTGTAAAAACCTAGGC 29




Trichophyton mentagrophytes 68A 1 TTTTTTTTTTGTTTAGCCACTAAAGAGAG 29
68A 2 TTTTTTTTTTGTTTAGCCACTAAAGAGA 28
68A 4R TTTTTTTTTTGTTTAGCCACTAAAGAGAGG 30
69A-10 GCCCCCGTCTTTGGGGGTTTTTTTTTTT 28
Trichophyton rubrum 66B 6R TTTTTTTTTTGCTCGAGGCTCCCAGAAGG 29
66B 13R TTTTTTTTTTCTCGAGGCTCCCAGAAGG 28
66B 14R TTTTTTTTTTGCTCGAGGCTCCCAGAAG 28
67A 1 TTTTTTTTTTCAGCCAATCCAGCGCCCTCA 30
67A 7 TTTTTTTTTTCAGCCAATCCAGCGCCCTC 29
67A 8 TTTTTTTTTTAGCCAATCCAGCGCCCTCA 29
67B 17 AGCCAATTCAGCGCCCTTTTTTTTTTT 27
67B 19 CAGCCAATTCAGCGCCCTCTTTTTTTTTT 29
Trichophyton tonsurans 47A 6 CCTATCCTGGGGGGCCTTTTTTTTTT 26
47A 7 TTTTTTTTTTCCTATCCTGGGGGGCC 26
47A 19R TTTTTTTTTTTATCCTGGGGGGCCGGCCT 29
47B 1 TTTTTTTTTTGAGCCGCTATAAAGAGAGG 29
47B 4 TTTTTTTTTTGAGCCGCTATAAAGAGAGGC 30
47B 19R GAGCCGCTATAAAGAGAGGTTTTTTTTTT 29
Trichosporon sp. 78A-3 TTTTTTTTTTCTTGCGCTCTCTGGTA 26
78C-1 TTTTTTTTTTGCTCGCCTTAAAAGAGTT 28
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Preparation of DNA Microarray Slides
The synthetic oligonucleotides were diluted to
20 pmol/ll in TE buffer and mixed with an equal
volume of 69 SSC [209 SSC is 3 M NaCl, 0.3 M
sodium citrate (pH7.0)] to make a final concentration
of 10 pmol/ll oligonucleotides in 39 SSC. The probe
solutions were spotted on NGK plastic slides (NGK
insulators LTD, Aichi, Japan) using a KCS-mini
microarray printer (Kubota Comps Corporation, Hy-
ogo, Japan). After spotting, the slides were irradiated
with UV at 0.6 J/cm2 using a UV cross-linker (model
CL-1000; UVP, San Gabriel, Ca) to fix the probes on
plastic slides. The slides were then gently shaken in
blocking buffer [3 % BSA, 0.2 M NaCl, 0.1 M Tris–
HCl (pH 8.0), and 0.05 % Triton X-100] for 5 min and
washed with TE buffer for 10 min. The array slides
were air-dried and stably stored at room temperature at
least 3 years.
Infectious Mouse Model
As an infection model, male ICR mice (Charles
River Laboratories) were infected intravenously with
Aspergillus fumigatus Af293 or Fusarium solani
complex IFM40718 (FSSC) conidia (1 9 106
conidia/mouse) in a 200 ll volume of saline. Three
mice were used in each fungal species. One hour
after infection, mice were killed, and blood was
collected from the heart tissues under sterilized
conditions. The CFU was determined by inoculating
100 ll of collected blood on a PDA with Chloram-
phenicol plate, and colonies were counted after 24 h
of cultivation at 30 C. Blood samples were used
directly as template for PCR.
Blood Culture
As the routine diagnosis of blood infection, blood
samples were taken from patients and cultivated using
the BD BACTEC FX system (BD, Tokyo, Japan) for
7 days, following the ethics of Chiba University
Hospital. After cultivation, growth positive samples
were inoculated onto several kinds of agar to identify
bacteria and/or fungi. For the microarray identifica-
tion, one growth positive and one growth negative
blood culture samples were used directly as a template
for PCR.
DNA Extraction
Fungal DNA was extracted as normal phenol–chloro-
form method. The conidia of A. fumigatus were
inoculated in PDB medium and cultivated for 2 days
at 37 C. The mycelium was collected by filtration and
ground by mortar using liquid N2. The ground cells
were suspended in DNA extraction buffer (200 mM
Tris, 25 mM NaCl, 25 mM EDTA, 0.5 % SDS, pH
8.5) and extracted with phenol/chloroform/isoamyl
alcohol. After that, RNase treatment and ethanol
precipitation were conducted. The cells of Candida
albicans were cultivated in PDB medium 1 day at
30 C. The cells were collected by centrifugation, and
the DNA was extracted using GenTorukun (TaKaRa
Bio Inc., Shiga, Japan).
PCR Amplification and Labeling
The 50-biotin-labeled fungus-specific universal prim-
ers ITS1-bio (50-TCCGTAGGTGAACCTGCGG-30)
Table 1 continued
Organism Probe name Probe sequence (50-30) Length (bp)
Trichosporon asahii 79A-5 TTTTTTTTTTGCGTCTGCGATTTCT 25
79A-6a TTTTTTTTTTGGGCGTCTGCAATTTC 26
Trichosporon cutaneum 31A-2 TTTTTTTTTTCGGTCAATTGATTTTACAAA 30
31A-4R TTTGTAAAATCAATTGACCGTTTTTTTTTT 30
32A 17 TTTTTTTTTTAACTTGTCTTATCTGGC 27
The probes with asterisk (*) shows cross-hybridization within the same genus
The ex-type classification name was used in some of the fungi
20 Mycopathologia (2014) 178:11–26
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and ITS4-bio (50-TCCTCCGCTTATTGATATGC-30)
[15] were used for amplifying the entire ITS region
and biotin labeling. The amplified fragment ranged
from 426 to 930 bp depending on the fungal species.
PCR was performed using MightyAmp DNA poly-
merase ver. 2 (TaKaRa Bio Inc.) in a total reaction
volume of 10 ll containing 1 ll of template (fungal
cell suspension, whole blood, serum, blood culture,
and extracted DNAs). Amplification was carried out as
follows, 2 min of initial denaturation at 98 C, 40
cycles of DNA denaturation at 98 C for 10 s, primer
annealing at 55 C for 15 s and elongation at 68 C for
45 s, and a final elongation step at 68 C for 5 min.
After the PCR reaction, amplification was verified by
electrophoresis. In case of low content of fungal cells
or DNA, nested PCR was performed using ITS1-n
(50-GAGGAAGTAAAAGTCG-30) and ITS4-n (50-TT
CACTCGCCGTTACT-30) as the first-round PCR
primer set. One ll of first-round PCR sample was
then used as template in the second round of PCR
performed in a total reaction volume of 10 ll.
Isothermal Amplification
Isothermal amplification was performed with a Twi-
stAmp basic kit (TwistDx Limited, Cambridge, UK).
Amplification was carried out at 37 C for 40 min
according to the manufacturer’s protocol using 1.5 ll
of fungal cell suspension or DNA as template.
Microarray Hybridization and Signal Detection
Before microarray hybridization, amplified and labeled
PCR samples were denatured at 95 C for 2 min and
chilled on ice for 2 min. Four ll of a denatured sample
was then mixed with 16 ll of hybridization buffer
(0.2 g tetramethylammonium chloride, 0.5 % SDS, and
1.9 mg EDTA in 1 ml of 6 9 SSC). Samples were
applied to the array slide, covered with a cover-film to
prevent sample evaporation, and incubated at 37 C for
1 h in a moist-chamber. Array slides were then washed
with PBS buffer at 37 C for 5 min. A color develop-
ment reaction was performed on the slide in accordance
with the avidin-biotinylated peroxidase complex (ABC)
method using a 3, 30, 5, 50-tetramethylbenzidine (TMB)
solution for visualization [16]. First, the conjugation
reaction was performed with streptavidin and biotin-
HRP for 30 min, and the array was washed twice with
PBST buffer (PBS buffer with 0.1 % Tween 20) for
5 min. After washing, color development was per-
formed with 0.02 % TMB, 0.015 % H2O2, and 0.5 mg/ml
alginic acid in 0.2 M acetate buffer (pH 3.3). Color
development was terminated after 30 min by washing
the array slides with distilled water. The results were
evaluated by visual observation.
Results
Design of Probes and DNA Microarray Slides
Because the ribosomal RNA gene, especially the 28S
rRNA gene, is highly conserved among species,
sequences of the ITS region are widely used for
identification of fungal species. We designed species-
and/or genus-specific probes within the ITS region and
tested the specificity of selected sequences using 355
reference strains (Table S1). Genus-specific probes
were designed for some fungi (Alternaria sp., Rhizo-
mucor sp., Mucor sp., Trichosporon sp.); because they
have highly conserved ITS region sequences within the
genus, we could not design species-specific probes. We
successfully designed 319 probes of species/genus-
specific oligonucleotides ranging from 13 to 21 bp
with a poly-T anchor at the 50 or 30 end for the
identification of 42 species from 24 genera of fungal
pathogens (Table 1). Three to twelve different specific
capture probes were designed and spotted on the array
slides for each fungal species/genus to ensure hybrid-
ization reaction for proper identification. Among the
319 probes, six universal probes for fungi were
designed, so that the array would give a positive signal
at universal probe even if fungal species in the tested
sample was not listed on the Table 1. In other words, 6
universal probes could detect any fungi other than
listed objective fungi without specific signal.
All designed probes and the positive control marker
(biotinylated-poly-T) were spotted on one plastic
slide. Figure 1a shows an example of the spot pattern
of the microarray slide.
Evaluation of the Specificity of DNA Microarray
Probes
To evaluate the specificity of the designed capture
probes, 66 fungal strains were used (Table S1). All
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fungal samples tested showed the expected species/
genus-specific hybridization patterns as shown in
Fig. 1b. Although some probes showed cross-hybrid-
ization within the same genus because of their highly
conserved sequence (e.g., Rhizopus stlonifer was
cross-hybridized to Rhizopus microsporus probes),
listed organisms are the major fungi causing infection
(Table 1). Moreover, the array system enabled us to
identify all the mixed fungi in one test even when
several fungal mixtures were used as template
(Fig. 1c). Resulted spot number is sometimes varied
depending on the sample (e.g., the spot of fungal
common probes in Fig. 1b), because the affinity of
each designed probes is different.
Sensitivity of the DNA Microarray System
To evaluate microarray detection sensitivity, we used
blood samples containing a known number of fungal
cells and serum with fungal DNA in place of actual
clinical samples. Serial ten-fold dilutions of fungal cells
in blood (106–100 CFU/ml) were prepared by adding A.
fumigatus conidia or C. albicans cells to rabbit whole
blood. The PCR reaction was performed directly using
1 ll of rabbit whole blood with or without fungal cells as
template (see Materials and Methods). After the PCR
reaction, amplification was verified by electrophoresis,
and the samples were used for microarray analysis










Fig. 1 a Example layout of capture probes on microarray slide.
Probe names correspond to probe names listed in Table 1. The
black column labeled ‘‘biotin’’ indicates the spots for positive
control (biotinylated-poly-T) and positional marker. b Typical
hybridization patterns using fungal suspension of different
fungal species as PCR template. Species-specific signals are
enclosed in solid line frames, while universal signals for fungi
are enclosed in dotted line frames. These figures show
representative results for A. fumigatus, Trichosporon asahii,
C. tropicalis, and C. albicans. c Simultaneous hybridization of
several species in one array slide. Fungal cell mixtures of C.
albicans, Cryptococcus neoformans, and T. asahii or of A.
fumigatus and Trichophyton rubrum were directly used as
template for PCR amplification and detected on the array slide
22 Mycopathologia (2014) 178:11–26
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103 CFU/ml was the minimum concentration needed
for PCR amplification followed by the microarray
detection. Although 102 CFU/ml could be considered as
the limit of detection, amplification at this concentration
is not reproducible. To increase the sensitivity, we
conducted nested PCR. However, it did not enhance the
sensitivity.
We also evaluated detection limits of A. fumigatus
and C. albicans DNA in serum. Extracted fungal DNA
ranging from 10 ng to 10 fg was separately added to
200 ll of rabbit serum. When 1 ll of the serum sample
was used directly as template for PCR, the detection
limit was 5 fg per 1 ll of serum. After nested PCR, the
minimal amount of DNA required for fungal identifi-
cation decreased to 0.05 fg per 1 ll of serum (Fig. 2b).
Identification of the Infected Fungi from Mice
Blood samples from infected mice were tested in place
of actual human clinical samples. After 1 h of fungal
infection, blood was collected and used directly for
PCR amplification. Because the first-round PCR did
not yield enough amplicon, nested PCR was per-
formed to increase the labeled amplicon, making it
possible to detect inoculated fungi in the blood from
the infected mouse by microarray. At this moment, the
CFU of A. fumigatus and FSSC remained in blood
stream were 500 ± 50 (colonies/ml) and 230 ± 30
(colonies/ml), respectively. This detection level is
consistent with the result of sensitivity test using rabbit
whole blood spiked with fungal cells.
Identification of the Fungi from Blood Culture
Sample
Blood from a patient was cultivated in a blood culture
bottle for 7 days; one culture positive and one nega-
tive sample were subjected to microarray analysis.
Samples from blood culture bottle were used directly
as a template for nested PCR amplification. The






















Fig. 2 Agarose gel electrophoresis of PCR products. a PCR
amplification of ITS region using blood sample spiked with A.
fumigatus cells as template. Upper panel shows the results of
normal PCR; lower panel shows the results of nested PCR.
Lanes: M, molecular marker (Gene Ladder Wide 1: NIPPON
GENE co., Tokyo, Japan); 1–7, blood sample spiked with
conidia. b PCR amplification of ITS region using serum sample
with C. albicans DNA as template. Upper panel shows the
results of normal PCR; lower panel shows the results of nested
PCR. Lanes: M, molecular marker; 1–8, DNA in 1 ml of serum
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microarray result was consistent with the identifica-
tion made by the Chiba University Hospital clinical
laboratory.
Isothermal Sample DNA Amplification
Because PCR amplification requires a thermal cycler,
which is not always available, in small hospitals, or in
less developed regions, we attempted to carry out
isothermal amplification for biotin labeling of sample
DNA using RPA technique [13]. The RPA cycle was
performed using 1.5 ll cell suspensions of various
fungi as template (Fig. 3). If amplification reaction
was successful, the microarray system we developed
gave correct identification results in all of the tested
samples, even though several amplification bands
were observed in some samples.
Discussion
Fungal infections cause severe morbidity and mortality
in immunocompromised patients. Early start of proper
treatment is crucial point to achieve better outcome in
these patients. Because sensitivity to antifungal drugs
differs among different fungal species, identification of
the causative fungal agent is important for proper
treatment. Rapid detection and identification of patho-
gens are therefore key points for diagnosis.
Recently, microarray methods have been developed
for the identification of a variety of pathogens,
including viruses [17], bacteria [4, 8], and fungi [5–
7]. These methods are powerful tools to simulta-
neously detect multiple pathogens. In this study, we
developed an easy-to-use, rapid and inexpensive
microarray method utilizing biotin-conjugated HRP
and color development of the substrate for signal
detection. In addition to making the detection system
straightforward, we immobilize DNA probes to
ordinary plastic slides without any surface modifica-
tion using UV irradiation via the poly-T anchor of the
capture probes [14]. This immobilization system
allowed us to use inexpensive, mass-produced, and
commercially available ordinary plastic slides as the
DNA microarray substrate.
For our DNA microarray, we selected ITS regions
of fungal rRNA genes as target because the ITS
sequence have been widely used to identify fungi.
Although it was difficult to design species-specific
probes for some of the fungal genera (Alternaria sp.,
Rhizomucor sp., Mucor sp., Trichosporon sp.), path-
ogenic species of these genera have similar MIC
values against several antifungal drugs, making
designing genus-specific probes useful [18–21]. To
our knowledge, the number of fungal species/genera
that could be identified by our array system, 42 species
from 24 genera, is the largest among microarray
identification systems reported to date [5–7]. And the
number of identifiable fungal species can be further
increased depending on demand of clinical use.
Considering the increasing incidence of infectious
diseases caused by fungi, this microarray system,
which can be used to identify a variety of fungi
simultaneously, has great potential.
The sensitivity of our microarray system was
evaluated using whole blood spiked with a certain
number of fungal cells and serum with fungal DNA.
When 1 ll of either sample was used directly as the
PCR template, the limit of the detection was 103
cells/ml for blood, and 5 pg/ml of DNA for serum.
Nested PCR increased the sensitivity to 50 fg/ml of
DNA in serum, but no change in sensitivity was
observed in the blood sample. According to calcu-
lations, in the 103 cells/ml blood sample, 1 ll of
template contains 1 cell, so in case of lower
concentration sample, 1 ll of template does not
contain any cells. That is why the amplification of
102 cells/ml sample was not constant and sensitivity
could not increase by nested PCR. However, DNA
extraction or concentration of cells from larger






Fig. 3 Isothermal amplification. Agarose gel electrophoresis of
fungal DNA obtained by isothermal amplification using
TwistAmp Basic kit. Lanes: M, molecular marker; Af, A.
fumigatus; Ca, C. albicans; Cn, Cryptococcus neoformans; Fs,
FSSC; Mf, Malassezia furfur; Ta, T. asahii; Ro, Rhizopus oryzae
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volume of blood or serum sample will have a
possibility to decrease detection limit.
When we tested the sample from an infected mouse
model and blood culture, it was difficult to get enough
intensity in microarray detection with only one step of
PCR amplification. This indicated that the amount of
DNA in the actual clinical samples is smaller than the
detection limit of our microarray system. Nested PCR,
however, increased the sensitivity of amplification,
and the nested PCR samples successfully gave the
expected diagnostic results.
The PCR step in conventional microarray systems
has remained as a crucial barrier for wide use in
laboratories or hospitals not equipped with a PCR
machine. In the present work, we adopted isothermal
amplification of DNA samples using the RPA tech-
nique as an alternative to PCR to solve this problem.
Although, the RPA technique has been used for rapid
identification of viruses and bacteria [13], this is the
first report of fungal DNA amplification by the RPA
technique directly from a fungal cell suspension
within 1 h. However, in the present study, the RPA
method was found to be less sensitive than the
conventional PCR technique. Further optimization of
sample preparation and RPA conditions are expected
to yield improved results.
In conclusion, we were able to establish a rapid
microarray system that can specifically identify a
variety of fungal pathogens. Furthermore, we demon-
strated that the ABC method could yield enough
sensitivity to detect signals from clinical samples,
providing an alternative to expensive fluorescence-
scanning methods. We also demonstrated that the
isothermal amplification technique in combination
with this array system has high potential for future
applications, such as for bedside diagnosis. This type
of assay technique enables simultaneous identification
of several agents in a few, relatively simple steps and
therefore will become a useful tool in the identification
of a wide range of both pathogenic and nonpathogenic
microorganisms.
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